即刻假体乳房重建术后感染的危险因素:11年病例对照研究
该11年病例对照研究评估了即刻组织扩张器/假体乳房重建术后手术部位感染的特异性危险因素,共纳入252例患者270例乳房。多因素分析显示,较高的体重指数、高血压、新辅助化疗、腋窝淋巴结清扫、血清肿形成和伤口愈合并发症与手术部位感染显著相关。研究结论提示,肥胖、高血压及接受新辅助化疗的女性感染风险增加,术后血清肿和伤口并发症亦增加风险。
要点
- 肥胖、高血压、新辅助化疗是即刻假体乳房重建术后感染的独立危险因素。
- 腋窝淋巴结清扫、血清肿和伤口愈合并发症与感染风险显著相关。
- 术前应基于上述危险因素进行患者选择和咨询。
核心结论
- 肥胖、高血压及接受新辅助化疗的女性即刻假体乳房重建术后手术部位感染风险增加。
- 术后血清肿和伤口并发症亦与手术部位感染风险增加相关。
研究设计与样本
- 回顾性病例对照研究,纳入2006年至2016年间连续接受即刻组织扩张器/假体乳房重建后发生手术部位感染的患者,并按年龄和手术日期匹配对照。
- 共评估252例患者270例乳房。
主要发现
- 多因素分析显示,体重指数每增加1点,感染风险OR为1.1(95%CI 1.0-1.2,p=0.02)。
- 高血压OR为6.5(95%CI 1.9-22.3,p=0.002)。
- 新辅助化疗OR为2.6(95%CI 1.0-6.3,p=0.04)。
- 腋窝淋巴结清扫OR为7.1(95%CI 1.7-29.2,p=0.006)。
- 血清肿形成OR为15.34(95%CI 3.7-62.5,p=0.0001),伤口愈合并发症OR为23.91(95%CI 6.1-93.4,p<0.0001)。
关键数值与推荐
- 手术部位感染定义采用美国疾病控制与预防中心标准,仅纳入需住院、静脉抗生素或手术干预的感染。
临床怎么用
- 对于肥胖、高血压及接受新辅助化疗的患者,应充分告知感染风险并个体化选择手术方案。
- 术后应积极预防和处理血清肿及伤口愈合并发症以降低感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical-site infection after implant-based breast reconstruction adversely affects surgical outcomes and increases health care costs. This 11-year case-control study examines risk factors specific for surgical-site infection after immediate tissue expander/implant-based breast reconstruction. METHODS: The authors performed a retrospective review to identify all consecutive patients with breast implant infections between 2006 and 2016. Patients who developed surgical-site infection after immediate tissue expander/implant-based breast reconstruction were included. Surgical-site infection was defined using the Centers for Disease Control and Prevention criteria; specifically, infections requiring hospital admission, intravenous antibiotics, or surgical intervention were included. The authors matched a control patient to each infection case by patient age and date of surgery. Patient demographics, medical comorbidities, and perioperative surgical variables were examined. Univariate and multivariable conditional logistic regression models were constructed. RESULTS: A total of 270 breasts in 252 patients were evaluated. On multivariate analysis, patients with a higher body mass index (OR, 1.1 per 1 body mass index point increase; 95 percent CI, 1.0 to 1.2; p = 0.02), hypertension (OR, 6.5; 95 percent CI, 1.9 to 22.3; p = 0.002), neoadjuvant chemotherapy (OR, 2.6; 95 percent CI, 1.0 to 6.3; p = 0.04), axillary lymph node dissection (OR, 7.1; 95 percent CI, 1.7 to 29.2; p = 0.006), seroma formation (OR, 15.34; 95 percent CI, 3.7 to 62.5; p = 0.0001), and wound healing complications (OR, 23.91; 95 percent CI, 6.1 to 93.4; p < 0.0001) were significantly associated with surgical-site infection. CONCLUSIONS: Women with obesity, women with hypertension, and those treated with neoadjuvant chemotherapy are at increased risk of surgical-site infection. Further risks are also associated with postoperative seroma and wound complications. This may help patient selection and counseling, adjusted based on risk factors regarding complications of immediate implant-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Banuelos J, Sabbagh MD, Roh SG, et al. Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg. 2019. PMID: 31764629. doi:10.1097/PRS.0000000000006202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。